Patents by Inventor Steven Garrett
Steven Garrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7101889Abstract: The invention relates to compositions for treating dandruff comprising compounds that are non-polymeric and/or have a weight average molecular weight of less than about 1000. These compounds, when used at a concentration of about 0.001% or less, inhibit the activity of any Malassezia globosa lipase by at least 50%. The invention also relates to the use of these compounds for inhibiting lipase activity.Type: GrantFiled: February 19, 2003Date of Patent: September 5, 2006Assignee: The Procter & GambleInventors: Joseph Robert Kaczvinsky, Jr., Charles Raymond Degenhardt, Garry Steven Garrett, Charles Winston Saunders, David Joseph Eickhoff, Celeste Dawn Gale, Nancy Lynn Reeder
-
Publication number: 20060162158Abstract: The present invention provides an apparatus for use in automated welding repairs, particularly those repairs intended for impellers and similar structures. In one embodiment, the invention provides an impeller weld restraining fixture. The fixture includes a base plate and top ring. An impeller may be sandwiched between the base plate and the ring mount. Tangs located on the top ring may be fitted to rest in the valley faces between airfoils on an impeller. Bolting the top ring to the base plate, with the impeller firmly secured therebetween, restrains the impeller so as to minimize warpage during welding repairs and heat treatments.Type: ApplicationFiled: January 26, 2005Publication date: July 27, 2006Inventor: Steven Garrett
-
Publication number: 20060085785Abstract: In one embodiment, methods and apparatus for configuring and/or monitoring a virtual machine in a resource group. In another embodiment, a method and apparatus for configuring and/or monitoring a resource group in accordance with a relocation policy that authorizes relocation of a resource from one cluster to another. In a further embodiment, a method and apparatus for configuring, monitoring and/or managing a resource group via a resource group tool having a user interface accessible via a web-services interface. In yet another embodiment, a method and apparatus for communicating between a console and at least one agent in a resource group tool via a web-services interface.Type: ApplicationFiled: October 15, 2004Publication date: April 20, 2006Inventor: Steven Garrett
-
Publication number: 20060085668Abstract: In one embodiment, methods and apparatus for configuring and/or monitoring a virtual machine in a resource group. In another embodiment, a method and apparatus for configuring and/or monitoring a resource group in accordance with a relocation policy that authorizes relocation of a resource from one cluster to another. In a further embodiment, a method and apparatus for configuring, monitoring and/or managing a resource group via a resource group tool having a user interface accessible via a web-services interface. In yet another embodiment, a method and apparatus for communicating between a console and at least one agent in a resource group tool via a web-services interface.Type: ApplicationFiled: October 15, 2004Publication date: April 20, 2006Inventor: Steven Garrett
-
Publication number: 20060085530Abstract: In one embodiment, methods and apparatus for configuring and/or monitoring a virtual machine in a resource group. In another embodiment, a method and apparatus for configuring and/or monitoring a resource group in accordance with a relocation policy that authorizes relocation of a resource from one cluster to another. In a further embodiment, a method and apparatus for configuring, monitoring and/or managing a resource group via a resource group tool having a user interface accessible via a web-services interface. In yet another embodiment, a method and apparatus for communicating between a console and at least one agent in a resource group tool via a web-services interface.Type: ApplicationFiled: October 15, 2004Publication date: April 20, 2006Inventor: Steven Garrett
-
Patent number: 7030156Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected such that the termiticide causes death to about 50 to about 100% of termites within about 24 to about 84 days after the termites begin to ingest the termiticide or the bait matrix comprising the termiticide, b) a cellulose containing material, and c) water. The termiticidal bait matrix can be used in a bait station installed in the ground. The kits are suitable to be used by consumers in their homes.Type: GrantFiled: June 17, 2002Date of Patent: April 18, 2006Assignee: University of Florida Research Foundation, IncInventors: Philip Frederick Brode, III, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Publication number: 20050274123Abstract: A thermocoustic device includes a housing with a thermal core supported in the housing and having a first and a second surface. The thermal core includes a first heat exchanger defining the first surface of the thermal core and a second heat exchanger defining the second surface of the thermal core. A main chamber is in fluid communication with the first surface of the thermal core and a secondary multiplier chamber is in fluid communication with the second surface of the thermal core. A working volume of a gaseous working fluid fills the main chamber, the multiplier chamber, and the thermal core at a pressure. An equilibrium pressure is defined as the pressure of the working volume of gaseous working fluids with the thermoacoustic device is in a non-operating mode.Type: ApplicationFiled: March 2, 2004Publication date: December 15, 2005Applicant: The Penn State Research FoundationInventors: Robert Smith, Matthew Poese, Ray Wakeland, Steven Garrett
-
Patent number: 6969512Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected such that the termiticide causes death to about 50 to about 100% of termites within about 24 to about 84 days after the termites begin to ingest the termiticide or the bait matrix comprising the termiticide, b) a cellulose containing material, and c) water. The termiticidal bait matrix can be used in a bait station installed in the ground. The kits are suitable to be used by consumers in their homes.Type: GrantFiled: October 10, 2002Date of Patent: November 29, 2005Assignee: The University of Florida Research Foundation, Inc.Inventors: Philip Frederick Brode, III, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews
-
Publication number: 20050028535Abstract: According to one embodiment of the present invention, a thermoacoustic device has a complaint enclosure which includes a rigid portion and a compliant portion. The compliant portion includes an oscillating member and a flexure seal with a pair of ends and a flexure body extending between the ends. One of the ends is sealed to the rigid portion and the other end is sealed to the oscillating member. The flexure seal has an average cross-sectional area and an end-to-end equilibrium length. A flexure volume is defined as the product of the average cross-sectional area and the end-to-end equilibrium length. A thermal core is disposed in the complaint enclosure and includes at least a first and a second heat exchanger. A working volume of gaseous working fluid fills the complaint enclosure. The working volume of gaseous working fluid has an equilibrium pressure.Type: ApplicationFiled: September 16, 2004Publication date: February 10, 2005Inventors: Matthew Poese, Robert Smith, Ray Wakeland, Steven Garrett
-
Publication number: 20040229912Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.Type: ApplicationFiled: June 21, 2004Publication date: November 18, 2004Applicant: Atrix Laboratories, Inc.Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
-
Patent number: 6773714Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.Type: GrantFiled: February 24, 2003Date of Patent: August 10, 2004Assignee: Atrix Laboratories, Inc.Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
-
Patent number: 6716421Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected such that the termiticide causes death to about 50 to about 100% of termites within about 24 to about 84 days after the termites begin to ingest the termiticide or the bait matrix comprising the termiticide, b) a cellulose containing material, and c) water. The termiticidal bait matrix can be used in a bait station installed in the ground. The kits are suitable to be used by consumers in their homes.Type: GrantFiled: March 5, 2001Date of Patent: April 6, 2004Assignee: University of Florida Research Foundation, Inc.Inventors: Philip Frederick Brode, III, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Publication number: 20030165449Abstract: The invention relates to compositions for treating dandruff comprising compounds that are non-polymeric and/or have a weight average molecular weight of less than about 1000. These compounds, when used at a concentration of about 0.001% or less, inhibit the activity of any Malassezia globosa lipase by at least 50%. The invention also relates to the use of these compounds for inhibiting lipase activity.Type: ApplicationFiled: February 19, 2003Publication date: September 4, 2003Applicant: The Procter & Gamble CompanyInventors: Joseph Robert Kaczvinsky, Charles Raymond Degenhardt, Garry Steven Garrett, Charles Winston Saunders, David Joseph Eickhoff, Celeste Dawn Gale, Nancy Lynn Reeder
-
Publication number: 20030133964Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.Type: ApplicationFiled: February 24, 2003Publication date: July 17, 2003Applicant: Atrix Laboratories, Inc.Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
-
Publication number: 20030124164Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies.Type: ApplicationFiled: October 10, 2002Publication date: July 3, 2003Applicant: The Procter & Gamble CompanyInventors: Philip Frederick Brode, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Patent number: 6565874Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.Type: GrantFiled: November 13, 2000Date of Patent: May 20, 2003Assignee: Atrix LaboratoriesInventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L Chandrashekar
-
Publication number: 20030017187Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies.Type: ApplicationFiled: June 17, 2002Publication date: January 23, 2003Applicant: The Procter & Gamble CompanyInventors: Philip Frederick Brode, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Publication number: 20020172658Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies.Type: ApplicationFiled: March 5, 2001Publication date: November 21, 2002Inventors: Philip Frederick Brode, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Patent number: 6121272Abstract: The invention provides compounds which are useful as inhibitors of metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having a structure according to Formula (I) ##STR1## as described in the claims, or an optical isomer, diastereomer or enantiomer thereof, or a pharmaceutically-acceptable salt, or biohydrolyzable alkoxyamide, ester, acyloxyamide, or imide thereof. Also disclosed are compounds, pharmaceutical compositions and methods of treating diseases characterized by metalloprotease activity using these compounds or the pharmaceutical compositions containing them.Type: GrantFiled: August 26, 1997Date of Patent: September 19, 2000Assignee: The Procter & Gamble CompanyInventors: Neil Gregory Almstead, Biswanath De, Rimma Sandler Bradley, Garry Steven Garrett, John Emory Marlin, II, John McMillan McIver, Zhe Wang, Yetunde Olabisi Taiwo